Hemodialysis And Peritoneal Dialysis Market Size, Share & Trends Analysis By Type (Hemodialysis, Peritoneal Dialysis), By Product (Device, Consumables, Service), By End-use (Home-based, Hospital-based), By Region, And Segment Forecasts, 2024 - 2030

Hemodialysis And Peritoneal Dialysis Market Size, Share & Trends Analysis By Type (Hemodialysis, Peritoneal Dialysis), By Product (Device, Consumables, Service), By End-use (Home-based, Hospital-based), By Region, And Segment Forecasts, 2024 - 2030


Hemodialysis And Peritoneal Dialysis Market Growth & Trends

The global hemodialysis and peritoneal dialysis market size is expected to reach USD 185.88 billion by 2030, registering a CAGR of 9.1% during the forecast period, according to a new report by Grand View Research, Inc. Increasing incidence of renal diseases, alongside the noteworthy growth in geriatric population has fueled the market demand for hemodialysis and peritoneal dialysis globally. Moreover, growing funding for the development of new products will provide a lucrative scenario for the market.

Over the recent past, the COVID-19 pandemic has been associated with surges in hospitalization and infection hotspots around the country. The pandemic led to a growth in demand for Renal Replacement Therapy (RRT) globally, owing to higher prevalence of comorbid conditions, such as Chronic Kidney Diseases (CKD), diabetes, and hypertension. The demand for dialysis machines surged significantly during this period. As per a research study published in American Society of Nephrology, the demand for dialysis machines required to manage cases of AKI amplified by 279% over baseline during the spring of 2020 in New York City.

Moreover, the rising prevalence of End-stage Renal Disease (ESRD) is likely to propel the market. For instance, according to USRDS, in 2020, there was an increase of 2.5% of people suffering from ESRD. A total of 130,400 new patients were registered who were treated for ESRD which accounted increase of 14.84% of people suffering from ESRD from 2010-2019.

Hemodialysis And Peritoneal Dialysis Market Report Highlights
  • Based on type, hemodialysis segment dominated the market in terms of value with a share of 82.71% in 2023 and is expected to grow at the highest CAGR of 6.0% during the forecast period. Rising number of ESRD patients, surge in geriatric population suffering from kidney diseases, are significant factors driving the segment growth.
  • Based on product, service segment dominated the market in 2023 with a share of 56.61%. Growing number of providers offering dialysis services coupled with the higher penetration of latest technology in the developed countries, is contributing to the segment growth.
  • In end-use scope, hospital-based segment dominated the market with a share of 76.75% in 2023, owing to increased focus of players in establishing independent dialysis centers, and growing preference of patients to opt for treatment in in-center dialysis.
  • North America dominated the hemodialysis and peritoneal dialysis market with the highest revenue share of 38.25% in 2023, owing to the presence of key participants, and high awareness about advanced dialysis devices among healthcare professionals & patients.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Product
1.1.3. End-useEnd use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Product outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Hemodialysis And Peritoneal Dialysis Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Increasing prevalence of acute kidney injury (AKI) and associated chronic kidney diseases
3.4.1.2. Increasing incidence and prevalence of ESRD
3.4.1.3. Introduction to technologically advanced products
3.4.1.4. Growing geriatric population
3.4.1.5. Increase in number of diabetes patient
3.4.2. Market Restraint Analysis
3.4.2.1. Risk and complications associated with dialysis
3.4.2.2. Issues with product approval and Commercialization
3.5. Hemodialysis And Peritoneal Dialysis Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Hemodialysis And Peritoneal Dialysis Market: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Hemodialysis
4.1.2. Peritoneal Dialysis
4.2. Type Market Share, 2023 & 2030
4.3. Segment Dashboard
4.4. Hemodialysis And Peritoneal Dialysis Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Hemodialysis
4.5.1.1. Hemodialysis market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2. Conventional
4.5.1.2.1. Conventional market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3. Short Daily Hemodialysis
4.5.1.3.1. Short daily Hemodialysis market estimates and Forecast 2018 to 2030 (USD Million)
4.5.1.4. Nocturnal Hemodialysis
4.5.1.4.1. Nocturnal Hemodialysis Market Estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Peritoneal Dialysis
4.5.2.1. Peritoneal dialysis market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.2. Continuous Ambulatory Peritoneal Dialysis (CAPD)
4.5.2.2.1. Continuous ambulatory peritoneal dialysis (CAPD) market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.3. Automated Peritoneal Dialysis (APD)
4.5.2.3.1. Automated peritoneal dialysis (APD) market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Hemodialysis And Peritoneal Dialysis Market: Product Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Device
5.1.2. Consumables
5.1.3. Service
5.2. Product Market Share, 2023 & 2030
5.3. Segment Dashboard
5.4. Hemodialysis And Peritoneal Dialysis Market by Product Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Device
5.5.1.1. Device market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.2. Machine
5.5.1.2.1. Machine market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.3. Dialyzers
5.5.1.3.1. Dialyzers Market Estimates and forecast 2018 to 2030 (USD Million)
5.5.1.4. Water Treatment System
5.5.1.4.1. Water treatment system market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.5. Others
5.5.1.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Consumables
5.5.2.1. Consumables market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.2. Bloodlines
5.5.2.2.1. Bloodlines market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.3. Concentrates
5.5.2.3.1. Concentrates market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.4. Catheters
5.5.2.4.1. Catheters Market Estimates and forecast 2018 to 2030 (USD Million)
5.5.2.5. Others
5.5.2.5.1. Others market Estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Service
5.5.3.1. Service market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Hemodialysis And Peritoneal Dialysis Market: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Home-Based
6.1.2. Hospital-Based
6.2. End-use Market Share, 2023 & 2030
6.3. Segment Dashboard
6.4. Hemodialysis And Peritoneal Dialysis Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Home-Based
6.5.1.1. Home-based market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Hospital-Based
6.5.2.1. Hospital-based market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Hemodialysis And Peritoneal Dialysis Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2023
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. Market Product, & Forecasts and Trend Analysis, 2018 to 2030
7.6. North America
7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.6.2. U.S.
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
7.6.3. Canada
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement scenario
7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
7.7. Europe
7.7.1. UK
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement scenario
7.7.1.5. UK market estimates and forecasts, 2018 - 2030
7.7.2. Germany
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
7.7.3. France
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement scenario
7.7.3.5. France market estimates and forecasts, 2018 - 2030
7.7.4. Italy
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement scenario
7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
7.7.5. Spain
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement scenario
7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
7.7.6. Denmark
7.7.6.1. Key country dynamics
7.7.6.2. Competitive scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement scenario
7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
7.7.7. Sweden
7.7.7.1. Key country dynamics
7.7.7.2. Competitive scenario
7.7.7.3. Regulatory framework
7.7.7.4. Reimbursement scenario
7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
7.7.8. Norway
7.7.8.1. Key country dynamics
7.7.8.2. Competitive scenario
7.7.8.3. Regulatory framework
7.7.8.4. Reimbursement scenario
7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
7.8. Asia Pacific
7.8.1. Japan
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement scenario
7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
7.8.2. India
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement scenario
7.8.2.5. India market estimates and forecasts, 2018 - 2030
7.8.3. China
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Regulatory framework
7.8.3.4. Reimbursement scenario
7.8.3.5. China market estimates and forecasts, 2018 - 2030
7.8.4. South Korea
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. Regulatory framework
7.8.4.4. Reimbursement scenario
7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
7.8.5. Australia
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Regulatory framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
7.8.6. Thailand
7.8.6.1. Key country dynamics
7.8.6.2. Competitive scenario
7.8.6.3. Regulatory framework
7.8.6.4. Reimbursement scenario
7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
7.9. Latin America
7.9.1. Brazil
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement scenario
7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
7.9.2. Mexico
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement scenario
7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
7.9.3. Argentina
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement scenario
7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
7.10. MEA
7.10.1. South Africa
7.10.1.1. Key country dynamics
7.10.1.2. Competitive scenario
7.10.1.3. Regulatory framework
7.10.1.4. Reimbursement scenario
7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
7.10.2. Saudi Arabia
7.10.2.1. Key country dynamics
7.10.2.2. Competitive scenario
7.10.2.3. Regulatory framework
7.10.2.4. Reimbursement scenario
7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
7.10.3. UAE
7.10.3.1. Key country dynamics
7.10.3.2. Competitive scenario
7.10.3.3. Regulatory framework
7.10.3.4. Reimbursement scenario
7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
7.10.4. Kuwait
7.10.4.1. Key country dynamics
7.10.4.2. Competitive scenario
7.10.4.3. Regulatory framework
7.10.4.4. Reimbursement scenario
7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. BD
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Baxter
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. B. Braun SE
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Medtronic
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Fresenius Medical Care AG
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. DaVita
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Asahi Kasei Medical Co., Ltd.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Nipro Corp.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Nikkiso Co., Ltd.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Cantel Medical
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings